Tom Sheperd named Chief Executive Officer of the BIOASTER Technology Research Institute
The Board of Directors of BIOASTER, the Technology Research Institute focused on infectious diseases and microbiology, announced the appointment of Dr. Tom Shepherd as Chief Executive Officer.
He succeeds Jacques Berger who, following his retirement from his previous position as Directeur Général Délégué of Sanofi Pasteur, had been asked to set up BIOASTER’s corporate and laboratory operations and establish the foundations for its future growth into a leading research institute.
Dr. Shepherd is a British citizen and, following his Ph.D. in Biochemistry obtained in Scotland, has committed over thirty years to life science research, development and commercialization, primarily in the pharmaceutical and biotechnology industries. He has extensive international experience having built and led corporate, business and R&D teams in four continents.
He has held CEO positions with CXR Biosciences and Vascular Flow Technologies in Scotland and with Neurotech S.A. in Paris and Rhode Island, USA, as well as Head of Business Development responsibilities at Kymab Ltd. in Cambridge, UK, Intrabiotics Pharmaceuticals and ICN (Valeant) Pharmaceuticals in California and various executive positions in marketing and R&D in the UK, Australia and South Korea.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
